Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (tcdd)

Carcinogenesis

Volumn 11, Issue 8, 1990, Pages 1335-1342

  Hébert, Charles D ^a,b   Cao, Qun Li ^a,c   Birnbaum, Linda S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; RADIOISOTOPE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DIOXINS; DNA; ENZYME INDUCTION; HUMAN; OXIDOREDUCTASES; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED;

EID: 0025061540     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/11.8.1335     Document Type: Article

References (39)

1. Weerasinghe, N.C.A and Gross, M.L. (1985) Origins of polychlorodibenzo-p-dtoxins (PCDD) and polychlorodibenzofurans (PCDF) in the environment.In Kamrin, M.A. and Rodgers, P.W. (eds). Dioxins in the Environment.Hemisphere, Washington, DC. pp. 133-151.
2. Beck, H., Eckart, K., Mathar, W. and Wittkowski, R. (1988) Occurrence ofPCDD and PCDF in different kinds of paper. Chemosphere, 17, 51-57
3. Amendola, G., Bama, D., Blosser, R., LaFleur, L., McBride, A, Thomas, F., Tieman, T. and Whittemore, R. (1989) The occurence and fate of PCDD’sand PCDF’s in five bleached kraft pulp and paper mills. Chemosphere, 18, 1181-1188.
4. Vos, J.G, Moore, J.A. and Zinkl, J.G. (1973) Effect of 2, 3, 7, 8-tetrachloro-dibenzo-p-dioxin on the immune system of laboratory animals. Environ. HealthPerspect., 5, 149—162.
5. Harris, M.W., Moore, J.A., Vos, J.G. and Gupta, B.N. (1973) General biologicaleffects of TCDD in laboratory animals. Environ. Health Perspect., 5, 101-109.
6. Schwetz, B.A., Norris, J.M., Sparschu, G.C., Rowe, V.K., Gehnng, P.J andEmerson, J.L (1973) Toxicology of chlorinated dibenzo-p-dioxins. Environ.Health Perspect., 5, 87-99.
7. McConnell, E E., Moore, J.A. and Dalgard, D.W. (1978) Toxicity of TCDD in Rhesus monkeys (Macaco mulatto) following a single oral dose. Toxicol.Appl. Pharmacol., 43, 175-187.
8. Puhvel, S.M., Sakamoto, M., Ertl, D.C. and Reisner, R.M (1982) Hairlessmice as models for chloracne: a study of cutaneous changes induced by topicalapplication of established chloracnegens. Toxicol. Appl. Pharmacol., 64, 492-503.
9. Poland, A., Knutson J.C. and Glover, E. (1984) Histologic changes producedby 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in the skin of mice carrying mutationsthat effect the integument. J. Invest. Dermatol., 83, 454-459.
10. McConnell, E.E. (1985) The clinicopathologtc changes in various species ofanimals caused by dibenzo-p-dioxins. In Kamrin, M.A. and Rodgers, P.W.(eds), Dioxins in the Environment. Hemisphere, Washington, DC, pp.225-230.
11. Hebert, C.D., Harris, M.W., Elwell, M.R. and Bimbaum, L.S. (1990) Relativetumor-promoting abilities and toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin(TCDD), 2, 3, 4, 7, 8-pentachlorodibenzofuran (PCDF) and 1, 2, 3, 4, 7, 8-hexa-chkjrodibenzofuran (HCDF) in hairless mice. Toxicol. Appl Pharmacol, 102, 362-377.
12. Courtney, JC. D. and Moore, J.A. (1971) Teratology studies with 2, 4, 5-tiichloro-phenoxyacetic acid and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl.Pharmacol., 20, 396-403.
13. Moore, J.A., Gupta, B.N., Zinkl, J.G. and Vos, J.G. (1973) Postnatal effectsof exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Environ. HealthPerspect., 5, 81—85.
14. Neubert, D. and Dillman, J. (1972) Embryotoxk effects in mice treated with2, 4, 5-trichlorophenoxyacetic acid and 2, 3, 7, 8-tetrachlorodibeqgo-p-dioxin.Arch. Pharmacol., 272, 243-264.
15. Moore, J.A. (1978) Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-para-dioxin. Ecol.Bull., 27, 134-144.
16. Pitot, H.C., Goldsworthy, T., Campbell, H.A. and Poland, A. (1980)Quantitative evaluation of the promotion by 2, 3, 7, 8-tetrachlorodibenzop-dioxinof hepatocarcinogenesis from diethylnitrosamine. Cancer Res., 40, 3613-3620.
17. Poland, A., Palen, D. and Glover, E. (1982) Tumour promotion by TCDD inskin of HRS/J hairless mice. Nature, 300, 271—273.
18. Nishizumi, M. and Masuda, Y. (1986) Enhancing effect of 2, 3, 4, 7, 8-penta-chlorodibenzofuran and 1, 2, 3, 4, 7, 8-hexachlorodibenzofuran on diethynitros-amine hepatocarcinogenesis in rats. Cancer Lett., 33, 333-339.
19. Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A. and Humiston, C.G. (1978) Results of a two year chrometoxicity and oncogenicity study of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in rats.Toxicol. Appl. Pharmacol., 46, 279-303.
20. Poland, A. W Knutson, J.C. (1982) 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin andrelated halogenated aromatic hydrocarbons. Examination of the mechanismsof toxicity. Anna. Rev. Pharmacol. Toxicol., 22, 517-554.
21. Knutson, J.C. and Poland, A. (1980) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin:failure to demonstrate toxicity in twenty-three cultured cell types. Toxicol.Appl. Pharmacol., 54, 377-383.
22. Gierthy J.F. and Crane, D. (1984) Reversible inhibition of in vitro epithelialcell proliferation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl.Pharmacol., 74, 91—98.
23. Milstone, L.M and LaVigne, J.F. (1984) 2, 3, 7, 8-Tetrachlorodibenzop-dioxininduces hyperplasia in confluent cultures of human keralinocytes. J. Invest.Dermatol., 82, 532-534.
24. Greenlee, W.F., Osborne, R., Dold, K.M., Hudson, L.G., Young, MJ. and Toscano, W.A., Jr (1987) Altered regulation of epidermal cell proliferationand differentiation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). InHodgson, E., Bend, J.R. and Philpot, R.M. (eds), Reviews in BiochemicalToxicology. Elsevier, Amsterdam pp. 1—35.
25. Rice, R.H. and Cline, P.R. (1984) Opposing effects of 2, 3, 7, 8-tetrachloro-dibenzo-p-dioxin and hydrocortisone on growth and differentiation of culturedmalignant human keralinocytes. Carcinogenesis, 5, 367-371.
26. Hudson, L.G., Shaikh, R., Toscano, W.A., Jr and Greenlee, W.F. (1983) Induction of 7-ethoxycoumarin-O-deethylase activity in cultured humanepithelial cells by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD): evidence forTCDD receptor. Biochem. Biophys. Res. Common., 115, 611—617.
27. Rheinwald, J G. and Beckett, M. A (1981) Tumorigenic keratinocyte linesrequiring anchorage and fibroblast support cultured from human squamouscell carcinomas. Cancer Res., 41, 1657-1663.
28. Osborne, R. and Greenlee, W.F. (1985) 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epithelial cells.Toxicol. Appl. Pharmacol., 71, 434-443.
29. Burke, M.D. and Mayer, R.T (1974) Ethoxyresoiufin: direct fluorimetnc assayof a microsomal O-dealkylation which is preferentially inducible by 3-meythylcholanthrene. Drug. Metabol. Dispos., 2, 583-588.
30. Pohl, R.J. and Fouts, J.R. (1980) A rapid method for assaying the metabolismof 7-ethoxyrcsorufin by microsomal subcellular fractions. Anal. Biochem., 107, 150-155.
31. Rice, R.H. and Green, H. (1979) Presence in human epidermal cells of a solubleprotein precursor of the cross-linked envelope: activation of the cross-linkingby calcium ions. Cell, 18, 681—694.
32. Steel, R.G.D. and Torrie J.H. (1980) Principles and Procedures of StatisticalInference, 2nd edn. McGraw-Hill, New York, p. 176.
33. Hudson, L.G., Toscano, W.A., Jr and Greenlee, W.F. (1986) 2, 3, 7, 8-tetra-chlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF)binding to basal cells from a human keratinocyte cell line. Toxicol. Appl.Pharmacol., 82, 481—492
34. Knutson, J.C. and Poland, A. (1980) Keratinization of mouse teratoma cellline XB produced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin: an in vitro modelof toxicity. Cell, 22, 27-36.
35. Greenlee, W.F., Dold, K.M. and Osborne, R. (1984) A proposed model forthe actions of TCDD on epidermal and thymic epithelial target cells. InPdand^A. and Kimbrough, R.D. (eds), Banbury Report 18. Cold Spring HarborLaboratory, Cold Spring Harbor, NY, pp. 435-440.
36. Sparks, R.L. and Scott, R.E. (1986) Transforming growth factor type p is aspecific inhibitor of 3T3 T mesenchymal stem cell differentiation. Exp. CellRes., 165, 345-352.
37. Scott, R.E., Rorine, D.L., Wille, J.J., Jr and Yun, K. (1982) Coupling of growtharrest and differentiation at a distinct state in the G| phase of the cell cycle:Gd. Proc. Natl. Acad. Sci. USA, 79, 845-849.
38. Pittelkow, M.R., Willed J., Jr and Scott, R.E. (1986) Two functionally distinctclasses of growth arrest states in human prokeralinocytes that regulateclonogenic potential. J. Invest. Dermatol., 86, 410—417.
39. Hebert, C.D. and Bimbaum, L.S. (1989) Lack of correlation between sensitivityto growth inhibition and receptor number for transforming growth factor-β(TGF-/3) in human squamous carcinoma cell lines. Cancer Res., 49, 3196-3202.